• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Adaptation of influenza A (H7N9) virus in primary human airway epithelial cells

tetano

Editor, Senior Moderator
Sci Rep. 2017 Sep 12;7(1):11300. doi: 10.1038/s41598-017-10749-5.
[h=1]Adaptation of influenza A (H7N9) virus in primary human airway epithelial cells.[/h] Huang DT[SUP]1,[/SUP][SUP]2[/SUP], Lu CY[SUP]3[/SUP], Chi YH[SUP]4[/SUP], Li WL[SUP]3[/SUP], Chang LY[SUP]3[/SUP], Lai MJ[SUP]3[/SUP], Chen JS[SUP]5[/SUP], Hsu WM[SUP]6[/SUP], Huang LM[SUP]7[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Influenza A (H7N9) is an emerging zoonotic pathogen with pandemic potential. To understand its adaptation capability, we examined the genetic changes and cellular responses following serial infections of A (H7N9) in primary human airway epithelial cells (hAECs). After 35 serial passages, six amino acid mutations were found, i.e. HA (R54G, T160A, Q226L, H3 numbering), NA (K289R, or K292R for N2 numbering), NP (V363V/I) and PB2 (L/R332R). The mutations in HA enabled A(H7N9) virus to bind with higher affinity (from 39.2% to 53.4%) to sialic acid α2,6-galactose (SAα2,6-Gal) linked receptors. A greater production of proinflammatory cytokines in hAECs was elicited at later passages together with earlier peaking at 24 hours post infection of IL-6, MIP-1α, and MCP-1 levels. Viral replication capacity in hAECs maintained at similar levels throughout the 35 passages. In conclusion, during the serial infections of hAECs by influenza A(H7N9) virus, enhanced binding of virion to cell receptors with subsequent stronger innate cell response were noted, but no enhancement of viral replication could be observed. This indicates the existence of possible evolutional hurdle for influenza A(H7N9) virus to transmit efficiently from human to human.


PMID: 28900138 DOI: 10.1038/s41598-017-10749-5
Free full text
 
Back
Top Bottom